Speakers

Expand/Collapse

Cathy Critchlow
Vice President, Center for Observational Research
Amgen

Day One

TUESDAY, SEPTEMBER 29

5:45 pm | End of Summit & Virtual Happy Hour Begins

9:55 am | Chair’s Opening Remarks

Day Two

WEDNESDAY, SEPTEMBER 30

9:55 am | Chair’s Opening Remarks

4:15 pm | Chair’s Closing Remarks & End of Conference

10:45 am | Strategic Vision for RWE Generation Across the Product Lifecycle

Glynn Dennis
Senior Director of Data Science
AstraZeneca

Day Two

WEDNESDAY, SEPTEMBER 30

12:45 pm | Considerations for integrating digital and sensor data into the RWD ecosystem

Maarten Beekman
Respiratory Medical Director, International Region
AstraZeneca

Day One

TUESDAY, SEPTEMBER 29

4:45 pm | Case Study: RWE Global Opportunities & Emerging Markets

10:00 am | Panel: Determining Where Value Lies in RWE

David Anstatt
Executive Director, Center for Observational Research & Data Sciences
Bristol-Myers Squibb

Day One

TUESDAY, SEPTEMBER 29

2:45 pm | Understanding the Global RWE Regulatory Landscape

Day Two

WEDNESDAY, SEPTEMBER 30

10:00 am | Panel: Integration Within the Pharmaceutical Community

Dan Ollendorf
Director, Value Measurement & Global Health Initiatives
Center for the Evaluation of Value and Risk in Health (CEVR)

Day One

TUESDAY, SEPTEMBER 29

5:15 pm | Setting Standards for RWE in Comparative Effectiveness Research: Methods, Transparency & Governance

Angela Dobes
Vice President, IBD Plexus
Crohn’s & Colitis Foundation

Day One

TUESDAY, SEPTEMBER 29

2:15 pm | Identifying Gaps in Current Patient Care Partnering to Accelerate Patient-Centric Real-World Evidence

10:00 am | Panel: Determining Where Value Lies in RWE

Dan Hennessy
Vice President, Medical Affairs
EMD Serono

Day One

TUESDAY, SEPTEMBER 29

10:45 am | Interweaving RWE into the Strategic Fiber of Therapeutic Areas

10:00 am | Panel: Determining Where Value Lies in RWE

Francis Campion
Principal Lead
MITRE

Day Two

WEDNESDAY, SEPTEMBER 30

12:15 pm | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform

Jason Walonoski
Department Head
MITRE

Day Two

WEDNESDAY, SEPTEMBER 30

12:15 pm | Synthea: Augmenting RWD & Synthetic Data into a Limitless Platform

Patricia Schepman
Director, Global HEOR
Pfizer

Day One

TUESDAY, SEPTEMBER 29

4:15 pm | RWE Pre & Post Launch Elements

Sheena Thakkar
Manager, Global HEOR
Pfizer

Day One

TUESDAY, SEPTEMBER 29

4:15 pm | RWE Pre & Post Launch Elements

Frida Schain
CEO & Founder
Schain Research

Day One

TUESDAY, SEPTEMBER 29

10:00 am | Panel: Determining Where Value Lies in RWE

Day Two

WEDNESDAY, SEPTEMBER 30

2:45 pm | Strategizing Market Access - Ensuring Implementation for the Whole of the Drug Development Continuum

Amy Place
Senior Director, Field Medical Affairs
Scholar Rock

Day Two

WEDNESDAY, SEPTEMBER 30

3:15 pm | Global Medical Affairs (GMA): Lessons Learnt from Creating a Department

Javier Jimenez
Executive VP RWE & Late Phase
Syneos Health

Day One

TUESDAY, SEPTEMBER 29

12:15 pm | How to Use RWE to Better Define Trial Protocol: Syneos’s Case Studies

Michael Lees
Head of Value, Evidence and Portfolio Strategy
Takeda

Day Two

WEDNESDAY, SEPTEMBER 30

10:00 am | Panel: Integration Within the Pharmaceutical Community

Ipek Stillman
Head, Globak Health Economics
Takeda

Day Two

WEDNESDAY, SEPTEMBER 30

10:00 am | Panel: Integration Within the Pharmaceutical Community

Thomas Kristensen
Global Health Economics Lead Takeda
Takeda

Day One

TUESDAY, SEPTEMBER 29

12:45 pm | RWE and Patient Advocacy – Patient Centricity

Michael Lacey
Global Health Economics Lead
Takeda

Day One

TUESDAY, SEPTEMBER 29

12:45 pm | RWE and Patient Advocacy – Patient Centricity

Omar Ali
Pharmacist Consultant
QIPP Adviser Payer Network

Day One

TUESDAY, SEPTEMBER 29

10:00 am | Panel: Determining Where Value Lies in RWE

Day Two

WEDNESDAY, SEPTEMBER 30

3:45 pm | Understanding Market Access Methodology

Miriam Fenton
Former Director, Real World Investigator at Takeda
Syneos Health

Day One

TUESDAY, SEPTEMBER 29

3:15 pm | Contextualising Real World Data to Ensure Real World Evidence

Richard Gliklich
CEO
OM1

Day Two

WEDNESDAY, SEPTEMBER 30

1:15 pm | Leveraging RWD across Clinical Development for Autoimmune and Chronic Diseases

Sudhir Ghuge
Associate Principal, RWD&I Technology Head India
ZS

Day Two

WEDNESDAY, SEPTEMBER 30

11:15 am | Pushing the envelope on RWE and RWD Analytics

Manish Menon
Associate Principal RWD&I India Head
ZS

Day Two

WEDNESDAY, SEPTEMBER 30

11:15 am | Pushing the envelope on RWE and RWD Analytics